DHPLC screening for mutations in progressive familial intrahepatic cholestasis patients

Rivka Shapiro, Yair Anikster, Tal Yardeni, Sigal Korem, Korina Hartman, Raanan Shamir, Efrat Broide, Arie Levine, Yoram Bujanover, Dani Bercovich

Research output: Contribution to journalArticlepeer-review


Progressive familial intrahepatic cholestasis (PFIC) is a group of rare heterogeneous autosomal recessive disorders characterized by metabolic defects in biliary proteins involved in the formation and transfer of bile acids in the liver. The genotype-phenotype correlation is not always clear. Mutations in the ATP8B1, BSEP and MDR3 genes have been associated with PFIC1, PFIC2 and PFIC3, respectively. This study sought to characterize the molecular genetic basis for PFIC subtypes in Israel. It was conducted on 14 children with PFIC and their families; 10 with a PFIC1 or PFIC2 phenotype and 4 with a PFIC3 phenotype. Using denaturing high-performance liquid chromatography (DHPLC), five different mutations were identified in four affected families: three novel mutations in BSEP (G19R-g181c, S226L-c803t and G877R-g2755a), one novel mutation in MDR3 (IVS146 t/c) and one heterozygous mutation in ATP8B1 (R600W, in a family with the PFIC1/PFIC2 phenotype). The cause of PFIC was identified in 20% of the families tested. These findings indicate the probable involvement of additional genes in PFIC and the need for further studies to determine whether the abnormality lies on the RNA or protein level. A better understanding of the phenotype-genotype correlation in PFIC will lead to improved diagnoses and treatments.

Original languageEnglish
Pages (from-to)308-313
Number of pages6
JournalJournal of Human Genetics
Issue number5
StatePublished - May 2010
Externally publishedYes


  • ATP8B1
  • BSEP
  • MDR3
  • Mutation analysis
  • PFIC1
  • PFIC2
  • PFIC3


Dive into the research topics of 'DHPLC screening for mutations in progressive familial intrahepatic cholestasis patients'. Together they form a unique fingerprint.

Cite this